Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · IEX Real-Time Price · USD
2.050
+0.010 (0.49%)
Mar 28, 2024, 4:30 PM EDT - Market closed

Checkpoint Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
4.9312.0754.7440.7726.082219.2335.0950.42
Cash & Cash Equivalents
4.9312.0754.7440.7726.082219.2335.0950.42
Cash Growth
-59.16%-77.95%34.25%56.35%18.56%14.41%-45.21%-30.41%-
Receivables
00.070.020.020.031.530.330.820.07
Other Current Assets
0.451.150.981.80.861.371.860.070.17
Total Current Assets
5.3813.2955.7342.626.9724.921.4135.9850.65
Total Assets
5.3813.2955.7342.626.9724.921.4135.9850.65
Accounts Payable
18.321.625.987.228.1213.096.373.671.79
Other Current Liabilities
0.1311.170000000
Total Current Liabilities
18.4332.7725.987.228.1213.096.373.671.79
Long-Term Debt
000000002.47
Total Long-Term Liabilities
000000002.47
Total Liabilities
18.4332.7725.987.228.1213.096.373.674.26
Total Debt
000000002.47
Retained Earnings
-314.33-262.49-199.86-143.19-120.11-95.4-59.03-36.35-13.89
Shareholders' Equity
-13.05-19.4829.7535.3818.8511.8115.0432.3146.4
Net Cash / Debt
4.9312.0754.7440.7726.082219.2335.0947.95
Net Cash / Debt Growth
-59.16%-77.95%34.25%56.35%18.56%14.41%-45.21%-26.83%-
Net Cash Per Share
0.261.377.207.307.397.708.5016.2948.65
Working Capital
-13.05-19.4829.7535.3818.8511.8115.0432.3148.86
Book Value Per Share
-0.70-2.213.916.345.344.136.6514.9947.08
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).